Skip to main content
. 2019 Sep 11;11(Suppl 2):S239–S245. doi: 10.1016/j.jcot.2019.09.009

Table 2.

Comparison of Fast Track patients where the length of stay is ≤ 3 days to long stayers (>3days).

Total n(%) Fast track 85(55) Long stay 70(45) p-value
Age, Mean (SD) 64(10) 69(10) 0.003
Female, N(%) 42(50) 28(40) 0.260
Height cm, Mean(SD) 167(10) 163(10) 0.015
Weight kg, Mean(SD) 81(16) 83(17) 0.513
BMI, Median(IQR) 28(26–32) 31(26–36) 0.038
ASA Score
1–2 N (%) 77(91) 45(64) <0.001
3–4 N (%) 8(9) 25(36)
Blood loss percentage, Mean(SD) 13(6) 13(7) 0.526
Tranexamic Acid
Yes, N (%) 52(61) 46(66) 0.854
No, N (%) 31 (36.5) 22(31)
Missing, N (%) 2(2.5) 2(3)
Tourniquet
Yes, N (%) 80(94) 68(97) 0.458
No, N (%) 5(6) 2(3)
Tourniquet Time Mean(%) 74(23) 78(29) 0.372
Drain 4(5) 1(1) 0.065
Side N (%)
Right 45(53) 28(40) 0.145
Left 40(47) 42(60)
Medial N (%) 71(83.5) 64(91) 0.158
Lateral N (%) 14(16.5) 6(9)
Technique N (%)
Navio 41(48) 26(37) 0.187
Brain Lab 14(16.5) 17(24)
Jig 25(29) 26(37)
PSI 5(6) 1(1)
Manufacturer N (%)
Accuris 47(55) 42(60) 0.643
Journey 12(14) 7(10)
Oxford Uni 26(31) 20(29)
Sigma 0(0) 1(1)
High Volume Surgeon N (%) 69(81) 60 (86) 0.521
Age>75 N(%) 12(14) 21(30) 0.014
BMI>30 N(%) 28(35) 35(52) 0.045
Any Comorbidity N(%) 60(48) 64(52) 0.001
Cardiovascular Disease N(%) 35(42) 49(58) <0.001
Respiratory Disease N(%) 5(29) 12(71) 0.037
Neuro-Psychiatric Disease N (%) 4(50) 4(50) 1.000
Immune System Disease N (%) 21(43) 28(57) 0.056
Diabetes N (%) 7(8) 18(26) 0.004
Hyperlipidemia N (%) 17(50) 17(50) 0.562
Hypertension N (%) 32(38) 43(61) 0.004
Any complication N (%) 2(2) 11(16) 0.003
Readmission N (%) 3 (4) 4 (6) 0.702